Sponsor content
180 result(s) found, displaying 71 to 80
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Nivolumab
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Nivolumab
-
Australian public assessment report (AusPar)Australian Public Assessment for Dasatinib
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EMPLICITI elotuzumab 400mg lyophilized powder for IV infusion vial.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Abatacept
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OPDIVO nivolumab 100 mg in 10 mL (10 mg/mL) concentrated solution for IV infusion vial.
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd